Page last updated: 2024-08-21

dexamethasone 21-phosphate and Congenital Adrenal Hyperplasia

dexamethasone 21-phosphate has been researched along with Congenital Adrenal Hyperplasia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Caron, KM; Clark, BJ; Parker, KL; Soo, SC; Stocco, DM; Wetsel, WC1

Other Studies

1 other study(ies) available for dexamethasone 21-phosphate and Congenital Adrenal Hyperplasia

ArticleYear
Targeted disruption of the mouse gene encoding steroidogenic acute regulatory protein provides insights into congenital lipoid adrenal hyperplasia.
    Proceedings of the National Academy of Sciences of the United States of America, 1997, Oct-14, Volume: 94, Issue:21

    Topics: Adrenal Cortex Hormones; Adrenal Glands; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Aldosterone; Animals; Animals, Newborn; Corticosterone; Corticotropin-Releasing Hormone; Dexamethasone; Disease Models, Animal; Embryo, Mammalian; Female; Fludrocortisone; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Hypothalamus; Lipid Metabolism; Lipids; Male; Membrane Proteins; Mice; Mice, Knockout; Ovary; Phosphoproteins; Rats; Sex Characteristics; Testis; Testosterone

1997